Top 10 at 11: This morning is all about lithium, graphite and the fight against Glioblastoma
"What do you mean you've been throwing all my investments into the nappy bin? They'll be worth a fortune when they mature..." Pic via Getty Images.
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading –for better or worse.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Ticker | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| CHM | Chimeric Therapeutic | 0.04 | 43% | 1,615,464 | $14,957,683 |
| AHN | Athena Resources | 0.004 | 33% | 137,500 | $3,211,403 |
| TON | Triton Min Ltd | 0.025 | 25% | 1,099,822 | $31,227,112 |
| CTO | Citigold Corp Ltd | 0.005 | 25% | 400,000 | $11,494,636 |
| CDT | Castle Minerals | 0.011 | 22% | 7,374,477 | $10,120,437 |
| KNM | Kneomedia Limited | 0.003 | 20% | 35,755 | $3,761,963 |
| MVL | Marvel Gold Limited | 0.012 | 20% | 43,750 | $8,637,907 |
| WC8 | Wildcat Resources | 0.55 | 20% | 6,392,662 | $478,790,772 |
| CR1 | Constellation Res | 0.13 | 18% | 93 | $5,489,597 |
| RNU | Renascor Res Ltd | 0.13 | 18% | 4,664,729 | $279,334,825 |
Chimeric Therapeutics (ASX:CHM) – Up following positive new data from a clinical trial, showing a 55% Disease Control Rate (DCR) was achieved in patients treated with CLTX CAR T, exceeding historical disease control rates of 20-37%.
Castle Minerals (ASX:CDT) – Up after the company upgraded its Kambale graphite project Mineral Resource Estimate by 38% to 22.4Mt at 8.6% TGC containing 1.9Mt.
Wildcat Resources (ASX:WC8) – Surging this morning on news of hitting 85m @ 1.25% lithium at Tabba Tabba, Including 9m at 3.0% Li2O from 199m and 13m at 2.3% Li2O from 136m.
Calidus Resources (ASX:CAI) – Up after SQM announced it’s buying 40% of Pirra Lithium from Haoma Mining NL. Calidus owns 30% of Pirra, which just found lithium 8km down the road from Wildcat at Tabba Tabba.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Ticker | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| MAP | Microbalifesciences | 0.22 | -27% | 914,723 | $90,525,320 |
| EMU | EMU NL | 0.0015 | -25% | 2,001,227 | $2,900,043 |
| GTG | Genetic Technologies | 0.002 | -20% | 1,790,999 | $28,854,145 |
| NZS | New Zealand Coastal | 0.002 | -20% | 20,170 | $4,167,525 |
| PEC | Perpetual Res Ltd | 0.015 | -19% | 66,666 | $11,445,317 |
| AL8 | Alderan Resource Ltd | 0.009 | -18% | 3,205,334 | $6,783,641 |
| FHS | Freehill Mining Ltd. | 0.0025 | -17% | 23,076 | $8,534,403 |
| MTL | Mantle Minerals Ltd | 0.0025 | -17% | 13,268,079 | $18,442,338 |
| RGL | Riversgold | 0.01 | -17% | 6,452,644 | $11,415,137 |
| NYR | Nyrada Inc. | 0.021 | -16% | 33,999 | $3,900,218 |
Microba Life Sciences (ASX:MAP) – Down sharply on news that a proposed $20 million entitlement offer to fund the acquisition of Invivo Clinical Limited (Invivo) has been fully underwritten by Bell Potter Securities and Morgans Corporate.
Riversgold (ASX:RGL) – down on news that maiden drilling has intersected 4m at 1.27% Li2O from 97m, including 1m at 2.44% Li2O from 98m at RGL’s Earl Grey East prospect.
Medallion Metals (ASX:MM8) – Down after its Ravensthorpe gold project PFS came in at 92koz per annum AuEq production and pre-tax cash flow of $85 million per annum over a 9 year mine life.
Related Stories
SUBSCRIBE
Get the latest breaking news and stocks straight to your inbox.
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
